Fig. 2: Time-kill data for the strains when subject to the PBD compounds or controls.

Selected K. pneumoniae and A. baumannii strains were subject to 4x MIC concentrations of either one of the lead PBD compounds (KMR-14-03, KMR-14-14, KMR-14-33, or PP-A148) or ciprofloxacin. Data for compounds KMR-14-33 and PP-A148 were reported previously9.